MARCH 3, 2020 Glytec and AdventHealth Highlight the Broad Impact of Electronic Glycemic Management at HIMSS 2020 As One-Third of Patients Experience Increased Hospital Stays, Readmissions and Costs Due to Hypoglycemia and Hyperglycemia, eGMS Improves Outcomes and Quality of Care WALTHAM, MASS. (March 3, 2020) – Glytec, the only provider of insulin management software across the continuum of care, today …
January 15, 2019
At a Cost of $10,405 Per Patient Stay, Hypoglycemia in The Hospital Cannot Be Ignored
A diabetes webinar hosted by the American Hospital Association and sponsored by Glytec showcased why hypoglycemia prevention is imperative to the safety of patients and to the economics of healthcare delivery.
Featured speakers, Dr. Richard Pratley of Florida Hospital System and Dr. Steven Edelman of UC San Diego Health, recently delivered a unified message to several hundred senior healthcare professionals attending an American Hospital Association webinar: Hypoglycemia [low blood sugar] in the hospital is a major patient safety risk with significant clinical and financial implications. A case study presented by Pratley further revealed that insulin-managed patients who experience severe hypoglycemia, or blood sugar less than 40 mg/dL, have longer stays, higher readmission and mortality rates, and an overall cost of care $10,405 greater than patients whose blood sugar remains in the normal range.
May 16, 2016
Orange Regional Medical Center Receives HIMSS Stage 7 Award Based Largely on Glytec’s Insulin Decision Support Solution
Our client, Orange Regional Medical Center, received a HIMSS Analytics Stage 7 Award based largely on its success implementing Glytec’s eGlycemic Management System® to support computer-based precision insulin dosing.
HIMSS Analytics® awarded Orange Regional Medical Center (ORMC), in Middletown, N.Y., with a Stage 7 Award. The award represents ORMC’s attainment of the highest level on the Electronic Medical Record Adoption Model (EMRAM)℠.